Abantu abane-rhinitis ye-alergic (AR) abangalawulwayo kunyango oluqhelekileyo banokunyangwa ngokusebenzisa i-alergy immunotherapy (AIT) elawulwa njengeepilisi, iinaliti okanye amathontsi. E-US, ukusetyenziswa kwe-sublingual immunotherapy njengeepilisi (SLIT-tablets) kulinganiselwe xa kuthelekiswa ne-subcutaneous immunotherapy (SCIT). Olu phononongo luphande ukhetho lwezigulane kwii-SLIT-tablets vs inyanga nenyanga okanye ngeveki ye-SCIT ngokwembono yesigulana sase-US.

Funda upapasho: https://www.dovepress.com/preference-for-immunotherapy-with-tablets-by-people-with-allergic-rhin-peer-reviewed-fulltext-article-PPA